Identification, validation and clinical implementation  of cancer biomarkers: Translational strategies of the EORTC PathoBiology group

Daidone, M.G.; Foekens, J.A.; Harbeck, N.; Martens, J.; Brunner, N.; Thomssen, C.; Hall, J.A.; Salgado, R.; Dittmer, J.; Geurts-Moespot, A.; Duffy, M.J.; Sweep, F.C.G.J.; Schmitt, M.; Allgayer, H.; Barlesi, F.; Bekka, N.; Berns, P.M.J.E.; Cardoso, F.; Christensen, I.J.; Ciccolini, J.; Diaz-Chico, J.C.; Eppenberger-Castori, S.; Ferno, M.; Figarella-Branger, D.; Gion, M.; Gluz, O.; Hegi, M.; Kos, J.; Ladomery, M.; Lah, T.T.; Lambein, K.; Lamy, P.J.; Libbrecht, L.; Liedtke, C.; Linderholm, B.; Lively, T.; Loibl, S.; Lykkesfeldt, A.E.; Martin, P.M.; Mazouni, C.; Muller, V.; Muracciole, X.; Ouafik, L.; Pantel, K.; Paradiso, A.; Pastoreková, Silvia; Rhodes, A.; Riegman, P.H.J.; Rimoldi, D.; Romain, S.; Skvortsova, I.; Sleijfer, S.; Span, P.N.; Spyratos, F.; Talieri, M.; Taube, S.; Tejpar, S.; Thomas, G.; Ulukaya, E.

doi:https://dx.doi.org/10.1016/S1359-6349(12)70021-6

Number of the records: 1

Identification, validation and clinical implementation of cancer biomarkers: Translational strategies of the EORTC PathoBiology group

Title	Identification, validation and clinical implementation of cancer biomarkers: Translational strategies of the EORTC PathoBiology group
Author	Daidone M.G.
Co-authors	Foekens J.A.
	Harbeck N.
	Martens J.
	Brunner N.
	Thomssen C.
	Hall J.A.
	Salgado R.
	Dittmer J.
	Geurts-Moespot A.
	Duffy M.J.
	Sweep F.C.G.J.
	Schmitt M.
	Allgayer H.
	Barlesi F.
	Bekka N.
	Berns P.M.J.E.
	Cardoso F.
	Christensen I.J.
	Ciccolini J.
	Diaz-Chico J.C.
	Eppenberger-Castori S.
	Ferno M.
	Figarella-Branger D.
	Gion M.
	Gluz O.
	Hegi M.
	Kos J.
	Ladomery M.
	Lah T.T.
	Lambein K.
	Lamy P.J.
	Libbrecht L.
	Liedtke C.
	Linderholm B.
	Lively T.
	Loibl S.
	Lykkesfeldt A.E.
	Martin P.M.
	Mazouni C.
	Muller V.
	Muracciole X.
	Ouafik L.
	Pantel K.
	Paradiso A.
	Pastoreková Silvia 1961 SAVVIR - Virologický ústav SAV ^ORCID
	Rhodes A.
	Riegman P.H.J.
	Rimoldi D.
	Romain S.
	Skvortsova I.
	Sleijfer S.
	Span P.N.
	Spyratos F.
	Talieri M.
	Taube S.
	Tejpar S.
	Thomas G.
	Ulukaya E.

Source document	European Journal of Cancer. Vol. 10, no. 1 (2012), p. 120 - 127
Language	eng - English
Document kind	rozpis článkov z periodík (rbx)
Citations	Duffy, M.J.ab , McGowan, P.M.ab , Harbeck, N.c , Thomssen, C.d , Schmitt, M. UPA and PAI-1 as biomarkers in breast cancer: Validated for clinical use in level-of-evidence-1 studies Breast Cancer Research Volume 16, Issue 4, August 22, 2014, Article number 428
	Brana, I.a, Berger, R.b, Golan, T.b, Haluska, P.c, Edenfield, J.d, Fiorica, J.e, Stephenson, J.d, Martin, L.P.f, Westin, S.g, Hanjani, P.h, Jones, M.B.i, Almhanna, K.j, Wenham, R.M.j, Sullivan, D.M.jk, Dalton, W.S.k, Gunchenko, A.i, Cheng, J.D.i, Siu, L.L.a, Gray, J.E. A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours British Journal of Cancer Volume 111, Issue 10, 11 November 2014, Pages 1932-1944
	DROBNA, Monika - SZARZYŃSKA-ZAWADZKA, Bronisława - DAWIDOWSKA, Małgorzata. T-cell acute lymphoblastic leukemia from miRNA perspective: Basic concepts, experimental approaches, and potential biomarkers. In Blood Reviews. ISSN 0268960X, 2018-11-01, 32, 6, pp. 457-472.
Category	ADMA - Scientific papers in foreign impacted journals registered in Web of Sciences or Scopus
Category of document (from 2022)	V3 - Vedecký výstup publikačnej činnosti z časopisu
Type of document	článok
Year	2012
Registered in	SCOPUS
DOI	10.1016/S1359-6349(12)70021-6

article

Publication activities

rok	CC	IF	IF Q (best)	JCR Av Jour IF Perc	SJR	SJR Q (best)	CiteScore
	N

rok vydania	rok metriky	IF	IF Q (best)	SJR	SJR Q (best)
2012	2011	5.536	Q1	2.514	Q1

Number of the records: 1